# China NMPA Drug Inspection - Guangdong Nanguo Pharmaceutical Co., Ltd. - Amoxicillin capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-nanguo-pharmaceutical-co-ltd/8348d354-0ce3-41da-8480-8730ec4892d1/
Source feed: China

> China NMPA drug inspection for Guangdong Nanguo Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Amoxicillin capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Guangdong Nanguo Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin capsules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/guangdong-nanguo-pharmaceutical-co-ltd/8ddbae1c-e6f0-4ab1-b5e2-9ffcb98ea1fd/